Tivicay and Diabetes - a phase IV clinical study of FDA data

Summary:

Diabetes is reported as a side effect among people who take Tivicay (dolutegravir sodium), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Isentress, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Diabetes when taking Tivicay. It is created by eHealthMe based on reports of 9,634 people who have side effects when taking Tivicay from the FDA, and is updated regularly.

What is Tivicay?

Tivicay has active ingredients of dolutegravir sodium. It is often used in hiv infection. eHealthMe is studying from 9,674 Tivicay users. Check the latest studies of Tivicay.

What is Diabetes?

Diabetes is found to be associated with 2,010 drugs and 2,856 conditions by eHealthMe. Check the latest studies of Diabetes.

On Jul, 13, 2026

9,634 people reported to have side effects when taking Tivicay.
Among them, 113 people (1.17%) have Diabetes.

Among these 113 people:

* Approximation only. Some reports may have incomplete information.

Do you take Tivicay and have Diabetes?

- Check whether Diabetes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tivicay:

Tivicay (9,674 reports)

Diabetes treatments and more:

Diabetes (466,613 reports)

How severe was Diabetes and when was it recovered:

Diabetes in Tivicay

Expand to all the drugs that have ingredients of dolutegravir sodium:

Diabetes and drugs with ingredients of dolutegravir sodium (90 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tivicay:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Diabetes:

Diabetes (2,010 drugs)

Browse all the conditions that are associated with Diabetes:

Diabetes (2,856 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dolutegravir sodium (the active ingredients of Tivicay) and Tivicay (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.